Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Depot Formulation”

26 trials

Showing 20 of 26 results

Very early researchStudy completedNCT04060043
What this trial is testing

Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
CMX Research 11
Early research (Phase 1)Study completedNCT03715634
What this trial is testing

Study of a Novel Subcutaneous Depot Formulation of Buprenorphine

Who this might be right for
Opioid-use Disorder
Indivior Inc. 12
Large-scale testing (Phase 3)Study completedNCT00731549
What this trial is testing

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 1,081
Large-scale testing (Phase 3)Study completedNCT00660010
What this trial is testing

Study of Lupron Depot In The Treatment of Central Precocious Puberty

Who this might be right for
Puberty, Precocious
Abbott 55
Large-scale testing (Phase 3)Study completedNCT03695237
What this trial is testing

Evaluate Leuprolide Acetate 45 mg 6-Month Formulation in Children With Central Precocious Puberty (CPP)

Who this might be right for
Central Precocious Puberty (CPP)
AbbVie 45
Large-scale testing (Phase 3)Study completedNCT00128531
What this trial is testing

Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
GP-Pharm 120
Early research (Phase 1)Study completedNCT01473953
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Liraglutide-depot in Healthy Subjects

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Healthy
Novo Nordisk A/S 31
Testing effectiveness (Phase 2)Study completedNCT04085341
What this trial is testing

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion

Who this might be right for
Diabetic Macular EdemaRetina Vein Occlusion
Graybug Vision 21
Large-scale testing (Phase 3)Study completedNCT00705783
What this trial is testing

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 843
Large-scale testing (Phase 3)Study completedNCT00706654
What this trial is testing

Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 937
Large-scale testing (Phase 3)Study completedNCT01710709
What this trial is testing

Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder

Who this might be right for
Bipolar I
Otsuka Pharmaceutical Development & Commercialization, Inc. 748
Not applicableStudy completedNCT00056654
What this trial is testing

Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Abbott 164
Early research (Phase 1)Study completedNCT03287505
What this trial is testing

Aripiprazole IM Depot for Chinese Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Beijing Research Institute 24
Early research (Phase 1)Ended earlyNCT04810208
What this trial is testing

Intratumoural Injection of a Novel NanoZolid®-Docetaxel Depot Formulation in Patients With Advanced Solid Tumours

Who this might be right for
Solid Tumor
Lidds AB 6
Large-scale testing (Phase 3)Study completedNCT01567527
What this trial is testing

Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 731
Testing effectiveness (Phase 2)Study completedNCT03953079
What this trial is testing

A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
Graybug Vision 56
Testing effectiveness (Phase 2)Study completedNCT00913263
What this trial is testing

An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the Prostate

Who this might be right for
Prostate Cancer
Lidds AB 24
Testing effectiveness (Phase 2)Study completedNCT00776074
What this trial is testing

A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.

Who this might be right for
Uterine Fibroids
Takeda 80
Early research (Phase 1)Study completedNCT01870999
What this trial is testing

A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 41
Testing effectiveness (Phase 2)Study completedNCT01348100
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients

Who this might be right for
Schizophrenia
Novartis Pharmaceuticals 81
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation